6,345 Shares in Astera Labs, Inc. $ALAB Purchased by Lisanti Capital Growth LLC

20 Aug 2026, 10:26 by Tristan Rich · The Markets Daily

Lisanti Capital Growth LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 6,345 shares of the company’s stock, valued at approximately $3,065,000.

Other large investors also recently bought and sold shares of the company. Royal Bank of Canada lifted its holdings in shares of Astera Labs by 167.3% in the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after acquiring an additional 95,409 shares during the last quarter. AQR Capital Management LLC increased its holdings in Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after purchasing an additional 7,756 shares during the last quarter. Empowered Funds LLC increased its holdings in Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after purchasing an additional 4,183 shares during the last quarter. First Trust Advisors LP raised its position in Astera Labs by 102.0% in the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after purchasing an additional 56,952 shares during the period. Finally, Brown Advisory Inc. raised its position in Astera Labs by 54.9% in the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after purchasing an additional 1,977 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

Positive Sentiment: Analyst upgrade: Northland Securities raised Astera Labs to “Outperform,” supporting the bullish case for the stock. Northland Securities Upgrades Astera Labs to Outperform
Positive Sentiment: AI connectivity demand: Coverage highlights record demand for Astera Labs’ connectivity products as AI data-center infrastructure expands. The company’s recent results reinforce that trend, with revenue up 104.5% year over year and earnings exceeding analyst expectations.
Positive Sentiment: Strong growth profile: Astera Labs has posted accelerating quarterly revenue growth, while rising earnings estimates and demand for AI connectivity make it appear attractive relative to Broadcom in one comparison. ALAB vs. AVGO: Which AI Infrastructure Stock Is the Better Buy Now?
Positive Sentiment: Platform expansion: Analysts argue Astera Labs is evolving beyond individual components into a broader AI-fabric platform, potentially increasing content per accelerator, customer stickiness and margins. Astera Labs: A Platform Getting Paid Like A Part
Neutral Sentiment: Insider transactions: CEO Jitendra Mohan, COO Sanjay Gajendra and General Counsel Philip Mazzara sold shares worth roughly $64 million combined. The filings state the sales were made to cover tax withholding on vested equity awards, making them less concerning than discretionary sales, though they may still weigh on sentiment. SEC insider transaction filing
Negative Sentiment: High valuation and volatility: With a price-to-earnings ratio above 140 and shares trading below their 50-day moving average, investors may be taking profits or reducing exposure despite strong fundamentals. The stock’s elevated beta also increases sensitivity to market and AI-sector sentiment.

Wall Street Analyst Weigh In

Several research analysts have recently commented on ALAB shares. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target for the company in a research report on Monday. Susquehanna lifted their target price on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. Rothschild & Co Redburn began coverage on shares of Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 price target on the stock. Needham & Company LLC increased their price target on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Finally, Barclays raised their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and a consensus target price of $333.00.

View Our Latest Research Report on ALAB

Insider Buying and Selling at Astera Labs

In other news, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total value of $3,551,700.00. Following the transaction, the director owned 75,688 shares in the company, valued at approximately $26,882,106.96. This represents a 11.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 419,244 shares of company stock worth $163,135,169. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Trading Down 4.8%

Shares of ALAB opened at $289.02 on Thursday. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The firm’s fifty day simple moving average is $355.88 and its 200-day simple moving average is $243.65. The firm has a market capitalization of $50.14 billion, a price-to-earnings ratio of 143.08 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s revenue was up 104.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Astera Labs Company Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.